Table 3. Results from the multivariable Cox regression examining factors associated with risk of death in patients with hepatocellular carcinoma.
Predict variables | Adjusted HR | 95% CI | P value |
---|---|---|---|
Race | |||
White | 1 | – | Reference |
Black | 1.07 | 0.91-1.26 | 0.38 |
Native American | 0.81 | 0.52-1.26 | 0.35 |
Asian | 0.76 | 0.66-0.87 | <0.001 |
Age (year) | |||
<40 | 1.12 | 0.76-1.66 | 0.57 |
40-59 | 1 | – | Reference |
60-69 | 0.98 | 0.86-1.11 | 0.74 |
≥70 | 1.21 | 1.06-1.38 | 0.01 |
Gender | |||
Male | 1 | – | Reference |
Female | 0.99 | 0.87-1.12 | 0.88 |
Tumor size (cm) | 1.01 | 1.01-1.01 | <0.001 |
Tumor grade | |||
I/II | 1 | – | Reference |
III/IV | 1.48 | 1.30-1.69 | <0.001 |
Stage at diagnosis | |||
Localized | 1 | – | Reference |
Regional spread | 1.42 | 1.26-1.61 | <0.001 |
Distant spread | 2.07 | 1.70-2.53 | <0.001 |
Unstaged | 1.16 | 0.60-2.27 | 0.66 |
AFP | |||
Negative | 1 | – | Reference |
Positive | 1.36 | 1.20-1.54 | <0.001 |
Cirrhosis | |||
F0 | 1 | – | Reference |
F1 | 1.39 | 1.20-1.58 | <0.001 |
Type of therapy | |||
None | 1 | – | Reference |
Radiation only | 0.81 | 0.60-1.08 | 0.15 |
Ablation | 0.52 | 0.44-0.61 | <0.001 |
Resection | 0.35 | 0.30-0.41 | <0.001 |
Transplant | 0.14 | 0.11-0.17 | <0.001 |
HR, hazard ratio; CI, confidence interval; tumor grade I, well differentiated; tumor II, moderately differentiated; tumor III, poorly differentiated; tumor IV, undifferentiated; AFP, alpha fetal protein; F0, fibrosis score 0-4, none to moderate fibrosis; F1, fibrosis score 5-6, severe fibrosis or cirrhosis.